Salidroside stimulates osteoblast differentiation through BMP signaling pathway

Area of Science:

• Pharmacology
• Biochemistry
• Cell Biology

Background:

• Salidroside (SAL) is a key component of Rhodiola rosea L. with various pharmacological effects.
• The specific role of SAL in bone metabolism is not well understood.
• Investigating SAL's impact on osteoblast differentiation is crucial for understanding its therapeutic potential.

Purpose of the Study:

• To investigate the effects of SAL on osteoblast differentiation and bone metabolism.
• To elucidate the molecular mechanisms underlying SAL's action on bone cells.
• To evaluate SAL's efficacy in an in vivo model of bone loss.

Main Methods:

• Utilized murine pluripotent mesenchymal cell line (C3H10T1/2) and osteoblastic cell line (MC3T3-E1).
• Assessed cell proliferation, alkaline phosphatase (ALP) activity, osteoblast marker gene expression, and mineralization.
• Analyzed the BMP signaling pathway, including gene expression, protein phosphorylation, and the effects of antagonists and inhibitors.
• Conducted in vivo studies using ovariectomized rats to assess bone loss reversal.

Main Results:

• SAL promoted cell proliferation and significantly increased ALP activity in both cell lines.
• SAL upregulated the mRNA expression of osteoblast marker genes and enhanced mineralization.
• SAL activated the BMP signaling pathway by increasing BMP gene expression and Smad1/5/8 and ERK1/2 phosphorylation.
• SAL treatment reversed bone loss in ovariectomized rats.

Conclusions:

• Salidroside regulates bone metabolism by activating the BMP signaling pathway.
• SAL demonstrates osteogenic effects, promoting differentiation and mineralization.
• SAL shows potential for treating bone loss conditions, such as osteoporosis.